Literature DB >> 16724857

Aegicerin, the first oleanane triterpene with wide-ranging antimycobacterial activity, isolated from Clavija procera.

Rosario Rojas1, Luz Caviedes, José C Aponte, Abraham J Vaisberg, Walter H Lewis, Gerardo Lamas, César Sarasara, Robert H Gilman, Gerald B Hammond.   

Abstract

An ethanol extract of the Peruvian plant Clavija procera, a member of the rare Theophrastaceae family, was fractionated using a colorimetric bioassay-guided protocol against Mycobacterium tuberculosis (MTB), yielding the oleanane triterpenoid aegicerin (1) as the active constituent. Its MIC values ranged between 1.6 and 3.12 microg/mL against 37 different sensitive and resistant MTB strains (1 H37Rv, 21 susceptible clinical isolates, 2 INH-resistant clinical isolates, and 13 MDR clinical isolates).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16724857      PMCID: PMC5507661          DOI: 10.1021/np050554l

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  26 in total

1.  The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru.

Authors:  P G Suárez; C J Watt; E Alarcón; J Portocarrero; D Zavala; R Canales; F Luelmo; M A Espinal; C Dye
Journal:  J Infect Dis       Date:  2001-07-18       Impact factor: 5.226

Review 2.  Natural antimycobacterial metabolites: current status.

Authors:  Adewole L Okunade; Memory P F Elvin-Lewis; Walter H Lewis
Journal:  Phytochemistry       Date:  2004-04       Impact factor: 4.072

Review 3.  Some thoughts on the future of ethnopharmacology.

Authors:  Geoffrey A Cordell; Michael D Colvard
Journal:  J Ethnopharmacol       Date:  2005-08-22       Impact factor: 4.360

4.  Tree species richness of upper Amazonian forests.

Authors:  A H Gentry
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

5.  Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay.

Authors:  S G Franzblau; R S Witzig; J C McLaughlin; P Torres; G Madico; A Hernandez; M T Degnan; M B Cook; V K Quenzer; R M Ferguson; R H Gilman
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

Review 6.  A review of antimycobacterial natural products.

Authors:  S M Newton; C Lau; C W Wright
Journal:  Phytother Res       Date:  2000-08       Impact factor: 5.878

7.  Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis.

Authors:  Juan-Carlos Palomino; Anandi Martin; Mirtha Camacho; Humberto Guerra; Jean Swings; Françoise Portaels
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

8.  New colorimetric cytotoxicity assay for anticancer-drug screening.

Authors:  P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

Review 9.  The National Cancer Institute: cancer drug discovery and development program.

Authors:  M R Grever; S A Schepartz; B A Chabner
Journal:  Semin Oncol       Date:  1992-12       Impact factor: 4.929

10.  Determination of MICs for Mycobacterium avium-M. intracellulare complex in liquid medium by a colorimetric method.

Authors:  R Gomez-Flores; S Gupta; R Tamez-Guerra; R T Mehta
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

View more
  9 in total

1.  Oleanolic and ursolic acids influence affect the expression of the cysteine regulon and the stress response in Escherichia coli.

Authors:  Anna M Grudniak; Anna Kurek; Jolanta Szarlak; Krystyna I Wolska
Journal:  Curr Microbiol       Date:  2011-01-09       Impact factor: 2.188

2.  Native New Zealand plants with inhibitory activity towards Mycobacterium tuberculosis.

Authors:  Emma A Earl; Mudassar Altaf; Rekha V Murikoli; Simon Swift; Ronan O'Toole
Journal:  BMC Complement Altern Med       Date:  2010-06-10       Impact factor: 3.659

Review 3.  A multipronged approach to the study of peruvian ethnomedicinal plants: a legacy of the ICBG-Peru Project.

Authors:  José C Aponte; Abraham J Vaisberg; Rosario Rojas; Michel Sauvain; Walter H Lewis; Gerardo Lamas; César Sarasara; Robert H Gilman; Gerald B Hammond
Journal:  J Nat Prod       Date:  2009-03-27       Impact factor: 4.050

4.  Secondary Metabolites from Plants Inhibiting ABC Transporters and Reversing Resistance of Cancer Cells and Microbes to Cytotoxic and Antimicrobial Agents.

Authors:  Michael Wink; Mohamed L Ashour; Mahmoud Zaki El-Readi
Journal:  Front Microbiol       Date:  2012-04-23       Impact factor: 5.640

Review 5.  Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition.

Authors:  Saikat Dewanjee; Tarun K Dua; Niloy Bhattacharjee; Anup Das; Moumita Gangopadhyay; Ritu Khanra; Swarnalata Joardar; Muhammad Riaz; Vincenzo De Feo; Muhammad Zia-Ul-Haq
Journal:  Molecules       Date:  2017-05-25       Impact factor: 4.411

Review 6.  Plants in our combating strategies against Mycobacterium tuberculosis: progress made and obstacles met.

Authors:  Vivek Kumar Gupta; M Madhan Kumar; Deepa Bisht; Anupam Kaushik
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 7.  The potential of plant systems to break the HIV-TB link.

Authors:  Peyman Habibi; Henry Daniell; Carlos Ricardo Soccol; Maria Fatima Grossi-de-Sa
Journal:  Plant Biotechnol J       Date:  2019-07-18       Impact factor: 9.803

8.  Molecular Docking Suggests the Targets of Anti-Mycobacterial Natural Products.

Authors:  Rafael Baptista; Sumana Bhowmick; Jianying Shen; Luis A J Mur
Journal:  Molecules       Date:  2021-01-18       Impact factor: 4.411

9.  Evaluation of the anti-mycobacterium tuberculosis activity and in vivo acute toxicity of Annona sylvatic.

Authors:  Rafaele C P Araujo; Francisco A R Neves; Anelise S N Formagio; Candida A L Kassuya; Maria E A Stefanello; Vanessa V Souza; Fernando R Pavan; Julio Croda
Journal:  BMC Complement Altern Med       Date:  2014-06-28       Impact factor: 3.659

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.